Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders

Objectives: In this retrospective multicenter study, we evaluated the safety of SARS-CoV-2 vaccination in patients harboring autoantibodies targeting neuronal surface and/or synaptic antigens. Methods: From eight Italian Neurology Units, we included patients with: a) serum and/or CSF positivity for...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinoto, Alessandro, Gastaldi, Matteo, Iorio, Raffaele, Marini, Sofia, Damato, Valentina, Farina, Antonio, Zoccarato, Marco, Sechi, Elia, Pinna, Francesca, Maniscalco, Giorgia Teresa, Barnabei, Ruggero, Zuliani, Luigi, Ferrari, Sergio, Mariotto, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035564/
https://www.ncbi.nlm.nih.gov/pubmed/35508101
http://dx.doi.org/10.1016/j.msard.2022.103827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035564/
https://www.ncbi.nlm.nih.gov/pubmed/35508101
http://dx.doi.org/10.1016/j.msard.2022.103827

Ejemplares similares